Prescribing treatments for lung cancer patients often involves invasive procedures like biopsies. However a new noninvasive blood test could change all this. Better yet, it costs less than $30.
Scientists have developed nanoparticles capable of targeting cancer tissue in the lungs. By engineering the devices to release their payloads only once they reach the site of the tumor, the researchers hope to reduce dosages and also limit the side effects of conventional treatments.
The developers of a promising new lung cancer detection tool have announced they are now moving into clinical trials. By relying on breath tests to diagnose the illness, it is hoped that the device could lead to non-invasive and earlier detection, ultimately boosting lung cancer survival rates